AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21852343 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based behavioral group intervention (Positively Fit; PF)
Number of subjects: 93
Study 21852343 — intervention group
Group type: COMPARATOR
Intervention: Brief family intervention (BFI)
Number of subjects: 93
Study 20457644 — intervention group
Group type: EXPERIMENTAL
Intervention: varenicline
Number of subjects: 2045
Study 20457644 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion sustained release
Number of subjects: 2045
Study 20457644 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2045
Study 17972024 — intervention group
Group type: EXPERIMENTAL
Intervention: EAP regimen (doxorubicin 40 mg/m², etoposide 360 mg/m², cisplatin 80 mg/m² every 28 days)
Number of subjects: 60
Study 17972024 — intervention group
Group type: COMPARATOR
Intervention: HD 5-FU (5-FU 2.6 g/m² 24 h infusion, biweekly)
Number of subjects: 60
Study 16898538 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective alpha1-blocker (doxazosin)
Number of subjects: 60
Study 16898538 — intervention group
Group type: COMPARATOR
Intervention: Behavioral therapy and rehabilitation
Number of subjects: 60
Study 14653830 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 250 mg t.d.s. for 10 days (Group A)
Number of subjects: 145
Study 14653830 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg b.d. for 10 days (Group B)
Number of subjects: 145
Study 10794751 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of intravenous ibandronate
Number of subjects: 20
Study 8799771 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity auditory stimuli (> 85 dB)
Number of subjects: 0
Study 8799771 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental noises (e.g., baby's crying)
Number of subjects: 0
Study 8799771 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory stimulation of different intensities
Number of subjects: 0
Study 8799771 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation of pleasant and unpleasant emotional reactions
Number of subjects: 0
Study 1634646 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine 5 mg
Number of subjects: 48
Study 1634646 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine 10 mg
Number of subjects: 48
Study 1634646 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine 20 mg
Number of subjects: 48
Study 1634646 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine 30 mg
Number of subjects: 48
Study 6746177 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐s sprint bouts on a hydraulically braked Fitron ergometer
Number of subjects: 27
Study 6746177 — intervention group
Group type: EXPERIMENTAL
Intervention: 60‐s sprint bouts on a hydraulically braked Fitron ergometer
Number of subjects: 27
Study 6746177 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed rides to exhaustion at 125% VO2max on an electrically braked Collins ergometer
Number of subjects: 27
Study 6746177 — intervention group
Group type: COMPARATOR
Intervention: All tests
Number of subjects: 27
Study 31673354 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand rub (ABHR) foam
Number of subjects: 36
Study 31673354 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand rub (ABHR) gel
Number of subjects: 36
Study 31673354 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ABHR products
Number of subjects: 36
Study 29893893 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 220
Study 29893893 — intervention group
Group type: COMPARATOR
Intervention: Entecavir
Number of subjects: 220
Study 26701117 — intervention group
Group type: EXPERIMENTAL
Intervention: P+HIIT (2 blocks per session of 3 different 15‐s plyometric exercises with 15‐s passive recoveries + HIIT program)
Number of subjects: 68
Study 26701117 — intervention group
Group type: EXPERIMENTAL
Intervention: P+HIIT
Number of subjects: 68
Study 26701117 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (2 blocks per session of 6‐8 bouts of 30‐s runs at 100% velocity at peak oxygen uptake)
Number of subjects: 68
Study 26701117 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 68
Study 24277644 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal administered at 2 hours post-dose
Number of subjects: 18
Study 24277644 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal administered at 6 hours post-dose
Number of subjects: 18
Study 24277644 — intervention group
Group type: COMPARATOR
Intervention: Apixaban alone
Number of subjects: 18
Study 24277644 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal administered at 2 or 6 hours post-dose
Number of subjects: 18
Study 22422538 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent hemodialysis (six times per week)
Number of subjects: 332
Study 22422538 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis (three times per week)
Number of subjects: 332
Study 18815591 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir 20 mg
Number of subjects: 0
Study 18575010 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.5 mg/ml) applied intra- and postoperatively for 5 minutes
Number of subjects: 30
Study 18575010 — intervention group
Group type: COMPARATOR
Intervention: Saline (control) applied in the contralateral side
Number of subjects: 30
Study 15707804 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound measurement of abdominal aortic diameter by emergency physicians
Number of subjects: 104
Study 12085859 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART)
Number of subjects: 68
Study 12085859 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cavity preparation
Number of subjects: 68
Study 12085859 — intervention group
Group type: COMPARATOR
Intervention: High-copper-content GK Amalgam Alloy (control)
Number of subjects: 68
Study 10102460 — intervention group
Group type: EXPERIMENTAL
Intervention: Melagatran (low dose)
Number of subjects: 48
Study 10102460 — intervention group
Group type: EXPERIMENTAL
Intervention: Melagatran (medium dose)
Number of subjects: 48
Study 10102460 — intervention group
Group type: EXPERIMENTAL
Intervention: Melagatran (high dose)
Number of subjects: 48
Study 10102460 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 48
Study 8697064 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (T)
Number of subjects: 0
Study 8697064 — intervention group
Group type: COMPARATOR
Intervention: Dihydrotestosterone (DHT)
Number of subjects: 0
Study 8697064 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 0
Study 2348224 — intervention group
Group type: EXPERIMENTAL
Intervention: liposome‐encapsulated doxorubicin (LED) at 30 mg/m2
Number of subjects: 14
Study 2348224 — intervention group
Group type: EXPERIMENTAL
Intervention: liposome‐encapsulated doxorubicin (LED) at 45 mg/m2
Number of subjects: 14
Study 2348224 — intervention group
Group type: EXPERIMENTAL
Intervention: liposome‐encapsulated doxorubicin (LED) at 60 mg/m2
Number of subjects: 14
Study 2348224 — intervention group
Group type: EXPERIMENTAL
Intervention: liposome‐encapsulated doxorubicin (LED) at 90 mg/m2
Number of subjects: 14
Study 2348224 — intervention group
Group type: EXPERIMENTAL
Intervention: liposome‐encapsulated doxorubicin (LED)
Number of subjects: 14
Study 375768 — intervention group
Group type: EXPERIMENTAL
Intervention: Dantrolene (100-150 mg)
Number of subjects: 48
Study 375768 — intervention group
Group type: COMPARATOR
Intervention: Suxamethonium
Number of subjects: 48
Study 31250168 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal instillation of 2% lidocaine gel (group A)
Number of subjects: 252
Study 31250168 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprostatic nerve block (PPNB) with 2% mepivacaine (group B)
Number of subjects: 252
Study 28510574 — intervention group
Group type: EXPERIMENTAL
Intervention: High initial dosage (10 vials) of Indian polyvalent antivenom
Number of subjects: 154
Study 28510574 — intervention group
Group type: COMPARATOR
Intervention: Low initial dosage (2 vials) of Indian polyvalent antivenom
Number of subjects: 154
Study 25522681 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 120
Study 25522681 — intervention group
Group type: COMPARATOR
Intervention: Spinal anaesthesia
Number of subjects: 120
Study 23442273 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Nonlinear Periodized (DNLP) training
Number of subjects: 38
Study 23442273 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonperiodized (NP) training
Number of subjects: 38
Study 23442273 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 21168464 — intervention group
Group type: EXPERIMENTAL
Intervention: RIS oral solution (mean dose, 3.7 mg)
Number of subjects: 81
Study 21168464 — intervention group
Group type: COMPARATOR
Intervention: RIS standard tablets (mean dose, 3.7 mg)
Number of subjects: 81
Study 21168464 — intervention group
Group type: EXPERIMENTAL
Intervention: RIS oral solution
Number of subjects: 81
Study 21168464 — intervention group
Group type: COMPARATOR
Intervention: RIS standard tablets
Number of subjects: 81
Study 21168464 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RIS oral solution and RIS standard tablets
Number of subjects: 81
Study 19506071 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror visual feedback
Number of subjects: 0
Study 17888158 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary School Free Breakfast Initiative (intervention group, 55 schools)
Number of subjects: 111
Study 17888158 — intervention group
Group type: COMPARATOR
Intervention: Control condition (control group, 56 schools)
Number of subjects: 111
Study 14750044 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 41
Study 14750044 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 41
Study 14750044 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive mood
Number of subjects: 41
Study 12645162 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta feedback, a non-pharmacologic technique
Number of subjects: 0
Study 12645162 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-model approach combining pharmacologic and non-pharmacologic interventions
Number of subjects: 0
Study 9802004 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couple Therapy (IBCT)
Number of subjects: 2
Study 9802004 — intervention group
Group type: COMPARATOR
Intervention: Traditional Behavioral Couple Therapy (TBCT)
Number of subjects: 2
Study 7618022 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 7.5 mg
Number of subjects: 462
Study 7618022 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 462
Study 7618022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 462
Study 7618022 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 7.5 mg and 10 mg
Number of subjects: 462
Study 2507698 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B1, B6, and B12 (Neurobion or Neurobion forte)
Number of subjects: 17
Study 2507698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 2507698 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 17
Study 666931 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural anaesthesia (mepivacaine, lignocaine, or bupivacaine)
Number of subjects: 241
Study 666931 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 241
Study 666931 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 241
Study 666931 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottle-fed subgroup
Number of subjects: 241
Study 666931 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-fed subgroup
Number of subjects: 241
Study 666931 — intervention group
Group type: COMPARATOR
Intervention: Control group (delivered without anaesthesia)
Number of subjects: 241
Study 31883339 — intervention group
Group type: EXPERIMENTAL
Intervention: Low baseline BNP (<50 pg/mL)
Number of subjects: 1782
Study 31883339 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately elevated baseline BNP (≥100 and <400 pg/mL)
Number of subjects: 1782
Study 31883339 — intervention group
Group type: EXPERIMENTAL
Intervention: Markedly elevated baseline BNP (≥400 pg/mL)
Number of subjects: 1782
Study 31883339 — intervention group
Group type: COMPARATOR
Intervention: Normal baseline BNP (≥50 and <100 pg/mL)
Number of subjects: 1782
Study 30301734 — intervention group
Group type: EXPERIMENTAL
Intervention: 17β-estradiol transdermal patch continuously with cyclic oral micronised progesterone (PATCH)
Number of subjects: 121
Study 30301734 — intervention group
Group type: COMPARATOR
Intervention: Combined ethinyl estradiol and desogestrel pill (PILL)
Number of subjects: 121
Study 30301734 — intervention group
Group type: COMPARATOR
Intervention: No oestrogen/progesterone (NONE)
Number of subjects: 121
Study 29130797 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 UA/day
Number of subjects: 158
Study 29130797 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 UA/day
Number of subjects: 158
Study 29130797 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 UA/day
Number of subjects: 158
Study 29130797 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 UA/day
Number of subjects: 158
Study 25510770 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech noise (45 dB)
Number of subjects: 40
Study 25510770 — intervention group
Group type: COMPARATOR
Intervention: Background noise (35 dB)
Number of subjects: 40
Study 25510770 — intervention group
Group type: EXPERIMENTAL
Intervention: Traffic noise (45 dB)
Number of subjects: 40
Study 25510770 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed noise (traffic and speech, 45 dB)
Number of subjects: 40
Study 23916525 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 42
Study 23916525 — intervention group
Group type: COMPARATOR
Intervention: Valproate
Number of subjects: 42
Study 21623743 — intervention group
Group type: EXPERIMENTAL
Intervention: CTG+ST (Cardiotocography plus ST analysis of fetal electrocardiogram)
Number of subjects: 5049
Study 21623743 — intervention group
Group type: COMPARATOR
Intervention: CTG-only (Cardiotocography only)
Number of subjects: 5049
Study 19537954 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention (details not provided)
Number of subjects: 184
Study 16529048 — intervention group
Group type: EXPERIMENTAL
Intervention: LHRH agonist
Number of subjects: 0
Study 16529048 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 0
Study 16529048 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study 16529048 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 0
Study 15270209 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian stimulation with smooth protocol and insemination of 5 million progressive motile sperm over two consecutive days
Number of subjects: 710
Study 15270209 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 710
Study 10978851 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dietary supplements (ODS) pre- and postoperatively
Number of subjects: 100
Study 10978851 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dietary supplements (ODS) preoperatively only
Number of subjects: 100
Study 10978851 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dietary supplements (ODS) postoperatively only
Number of subjects: 100
Study 10978851 — intervention group
Group type: COMPARATOR
Intervention: No oral dietary supplements (Control group)
Number of subjects: 100
Study 8818086 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A received 2 x 10(6) units of aprotinin 15 min before ECC and 0.5 x 10(6) unit immediately after ECC.
Number of subjects: 14
Study 8818086 — intervention group
Group type: COMPARATOR
Intervention: Group B received 0.5 x 10(6) unit of aprotinin 15 min before ECC and 2 x 10(6) units immediately after ECC.
Number of subjects: 14
Study 8818086 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received aprotinin at different dosages and timings.
Number of subjects: 14
Study 1681563 — intervention group
Group type: EXPERIMENTAL
Intervention: Abecarnil 3-9 mg/day
Number of subjects: 0
Study 1681563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1681563 — intervention group
Group type: EXPERIMENTAL
Intervention: Abecarnil 15-30 mg/day and 7.5-15 mg/day
Number of subjects: 0
Study 6130080 — intervention group
Group type: EXPERIMENTAL
Intervention: buspirone, 20 mg/day
Number of subjects: 1000
Study 6130080 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam, 20 mg/day
Number of subjects: 1000
Study 6130080 — intervention group
Group type: EXPERIMENTAL
Intervention: clorazepate, 23 mg/day
Number of subjects: 1000
Study 6130080 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1000
Study 30461447 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary brachial plexus block
Number of subjects: 82
Study 30461447 — intervention group
Group type: COMPARATOR
Intervention: Infraclavicular brachial plexus block
Number of subjects: 82
Study 30461447 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82
Study 27605024 — intervention group
Group type: EXPERIMENTAL
Intervention: Finalized data abstraction tool
Number of subjects: 1440
Study 27605024 — intervention group
Group type: COMPARATOR
Intervention: Preliminary data abstraction tool
Number of subjects: 1440
Study 25785969 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-valent polysaccharide conjugate vaccine (PCV13)
Number of subjects: 84496
Study 25785969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84496
Study 23878205 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee sleeve alone
Number of subjects: 0
Study 23878205 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic resonance electrical stimulation with knee sleeve
Number of subjects: 0
Study 23878205 — intervention group
Group type: COMPARATOR
Intervention: Control1 (no electrical stimulation/sleeve)
Number of subjects: 0
Study 23878205 — intervention group
Group type: COMPARATOR
Intervention: Control2
Number of subjects: 0
Study 22178632 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training prior to endurance training (SE)
Number of subjects: 26
Study 22178632 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training after endurance training (ES)
Number of subjects: 26
Study 20730057 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient fortified milk (MN milk)
Number of subjects: 633
Study 20730057 — intervention group
Group type: COMPARATOR
Intervention: Control milk (Co milk)
Number of subjects: 633
Study 18947396 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipoplus 20% (50% MCT, 40% LCT, 10% omega‐3) administered at a dose of 0.12 g/kg/h for 12 hours
Number of subjects: 16
Study 18947396 — intervention group
Group type: COMPARATOR
Intervention: Intralipid Fresenius Kabi (100% LCT) administered at a dose of 0.12 g/kg/h for 12 hours
Number of subjects: 16
Study 15833501 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) 300 mg
Number of subjects: 380
Study 15833501 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) 600 mg
Number of subjects: 380
Study 15833501 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) 900 mg
Number of subjects: 380
Study 15833501 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) (all dosages)
Number of subjects: 380
Study 11791087 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated estrogen 0.625 mg and medroxyprogesterone acetate 2.5 mg per day
Number of subjects: 18
Study 11791087 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced dose of oral conjugated estrogen
Number of subjects: 18
Study 11791087 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplement (control group)
Number of subjects: 18
Study 11791087 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (full and reduced dose)
Number of subjects: 18
Study 10527987 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened exposure of oocytes to spermatozoa
Number of subjects: 158
Study 10527987 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment time (standard IVF procedure)
Number of subjects: 158
Study 7724171 — intervention group
Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy (PRK)
Number of subjects: 106
Study 2756927 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrostatic weighing without head submersion (HWNS)
Number of subjects: 80
Study 1066813 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel (0.2% chlorhexidine gluconate) used 3 times a day for 6 weeks
Number of subjects: 16
Study 1066813 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine solution (various concentrations: 0.05%, 0.1%, 0.15%, 0.2%) rinsed twice a day for 7 days
Number of subjects: 16
Study 1066813 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 16
Study 1066813 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 16
Study 31313755 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation intervention over 12 months
Number of subjects: 104
Study 31313755 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study 31313755 — intervention group
Group type: COMPARATOR
Intervention: Hamilton anxiety scale
Number of subjects: 104
Study 31313755 — intervention group
Group type: COMPARATOR
Intervention: Beck's depression inventory
Number of subjects: 104
Study 29465209 — intervention group
Group type: EXPERIMENTAL
Intervention: Vizomitin (eye drops)
Number of subjects: 70
Study 29465209 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural tear
Number of subjects: 70
Study 29465209 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific pharmacological prevention)
Number of subjects: 70
Study 25959261 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial-based pacing at increased heart rate
Number of subjects: 239
Study 24041309 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipated regret questionnaire
Number of subjects: 60000
Study 24041309 — intervention group
Group type: COMPARATOR
Intervention: Control questionnaire
Number of subjects: 60000